AzTrials
AzTrials

PTSD - Post Traumatic Stress DisorderNCT06710145

The Effect of Using the Combat Attention App on the Risk of Post-traumatic Symptoms

An observational study of PTSD - Post Traumatic Stress Disorder, run by Tel Aviv University at 1 site in Israel.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Military service and reserve duty in combat units entails exposure to traumatic events that require mental adjustment. In light of the results of controlled studies that proved the effectiveness an response-time based mechanized training protocol in reducing risk for post-trauma symptoms in deployed combat soldiers… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
PTSD - Post Traumatic Stress Disorder
What is being tested?
Combat Attention Training
How many people
1,000 participants
Where
1 siteIsrael
Study dates
1 Jan 2026to 31 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of enlisted and reservist soldiers who participated in the Iron Swards war and either used or did not use the attention App.

Who may be able to join

  • Age over 18 years.
  • Served as an enlisted soldier or reservist during the Iron Swards War.
  • Used the Combat Attention App or can serve as a matched control who did not use the App.
  • Colloquial Hebrew sufficient to fill out the research questionnaires.

Who cannot join

  • Below 18 years of age.
  • Colloquial Hebrew that is insufficient to fill out the research questionnaires.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yair Bar-Haim, PhD contact

+972-3-6405465

yair1@tauex.tau.ac.il

Chelsea Gober Dykan, MA contact

+972-3-6405465

chelseagober@mail.tau.ac.il

Israel1 site
  • Tel Aviv University

    Tel Aviv

Other trials in Israel

About this study

Military service and reserve duty in combat units entails exposure to traumatic events that require mental adjustment. In light of the results of controlled studies that proved the effectiveness an response-time based mechanized training protocol in reducing risk for post-trauma symptoms in deployed combat soldiers, the Israeli Defense Forces decided at the beginning of the Iron Swords War to implement an internet-based App of the intervention. Soldiers and combat reservists were invited to use the Combat Attention App. The purpose of this study is to examine the effectiveness of the Combat Attention App in relation to a control group of soldiers who did not use the App in reducing risk for post-traumatic stress symptoms of deployed soldiers.

Read the detailed description

Participants who used the Combat Attention App before combat deployment and a group of matched (age and sex) participants who did not use the App will be compared on PTSD, depression, and anxiety symptoms post deployment.

Being tested
Combat Attention Training
Medical subject headings
Combat Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combat Attention TrainingBehavioural

    The Combat Attention App is a response-time based mechanized preventive intervention designed to train combat soldiers' attention toward threats before combat exposure in order to reduce the risk for combat-related post-trauma symptoms. In light of the results of controlled studies that proved the efficacy of this preventive intervention, the Israel Defense Forces (IDF) decided at the beginning of the Iron Swords War (October 7th, 2023) to implement an internet-based App of the intervention, and soldiers and combat reservists were invited to train on the Combat Attention App.

Study groups in NCT06710145
Study groupRoleWhat they receive
Attention App UsersSoldiers who used the App and completed at least one training session
Receives: Behavioral: Combat Attention Training
Non UsersSoldiers matched on age, sex, and specialty to the Attention App Users group who never used the App

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PTSD Checklist for DSM-5 (PCL-5)

    Measures PTSD symptoms according to DSM-5

    Measured: January-June 2025

  2. IDF Medical Records

    Holds all the medical information and contact with health/mental health professionals during one's service

    Measured: January-June 2025

Secondary outcomes (5)
  1. Combat Experiences Scale

    Measures the occurrence of specific combat events

    Measured: January-June 2025

  2. Patient Health Questionnaire 9 (PHQ-9)

    Measures Depression symptoms according to DSM-5

    Measured: January-June 2025

  3. Attention Bias Questionnaire (ABQ)

    Measures subjective experiences of attention allocation to threats

    Measured: January-June 2025

  4. GAD-7

    measures symptoms of generalized anxiety disorder

    Measured: January-June 2025

  5. Dissociative Experiences Scale (DES)

    measures dissociative symptoms associated with trauma exposure

    Measured: January-June 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Nov 2024
  2. Study start1 Jan 2026 (estimated)
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Other
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06710145
Sponsor's protocol ID
TAU-Combat-Attention
Status last verified
Apr 2025
First submitted
31 Oct 2024
Last updated
11 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wald I, Fruchter E, Ginat K, Stolin E, Dagan D, Bliese PD, Quartana PJ, Sipos ML, Pine DS, Bar-Haim Y. Selective prevention of combat-related post-traumatic stress disorder using attention bias modification training: a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2627-36. doi: 10.1017/S0033291716000945. Epub 2016 Jul 5.

    PubMed 27377418

Questions about this trial

What is this clinical trial studying?

An observational study of PTSD - Post Traumatic Stress Disorder, run by Tel Aviv University at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yair Bar-Haim, PhD (+972-3-6405465, yair1@tauex.tau.ac.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PTSD Checklist for DSM-5 (PCL-5) (time frame: January-June 2025). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06710145, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in